Cannabis finance news

Epsilon’s record quarter evidence of ‘remarkable turnaround’, says CEO

by Steve Jones November 8, 2025November 8, 2025

Epsilon Healthcare has delivered record quarterly receipts of almost A$3 million, with its chief executive describing […]

Chemist Warehouse cools on Astrid deal as negotiations stall

by Steve Jones November 6, 2025November 6, 2025

Time runs out for Biortica-Bod reverse takeover with focus to switch to IPO

by Steve Jones November 6, 2025November 6, 2025

Rua launches NZ$2m capital raise in bid to reach ‘self-sustaining position’

by Adam Sheldon November 4, 2025February 21, 2026

Financial news in brief: Elixinol addresses funding concerns; Aurora growth helped by Australia; Avecho lifts cash, progresses trial; Cann receives NAB extension to finalise settlement; IRX reports lean quarter

by Adam Sheldon November 4, 2025February 21, 2026

Little Green Pharma revenue climbs 10% to $10m in September quarter

by Adam Sheldon October 30, 2025November 3, 2025

Record revenue for Bioxyne but cash deficit rises after flower investment

by Steve Jones October 30, 2025November 3, 2025

‘Our vision can still be realised’, insists Cannim founder after firm calls in administrator

by Steve Jones October 27, 2025November 3, 2025

NAB agrees to write off $54m of Cann Group debt

by Steve Jones October 27, 2025February 21, 2026

News in brief: Cann Group trading halt; Avecho raises $2.5m for CBD submission; IRX CEO takes shares over salary

by Adam Sheldon October 23, 2025February 21, 2026